May 6 |
Pfizer: Ignore The Dead Cat Bounce
|
May 6 |
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
|
May 6 |
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
|
May 6 |
BioNTech says 90% of 2024 revenues will accrue at end of year
|
May 6 |
Pfizer Announces New Chief Strategy and Innovation Officer
|
May 5 |
3 No-Brainer Stocks to Buy in May
|
May 4 |
Pharma R&D productivity seen improving for the first time in years - Deloitte
|
May 4 |
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
|
May 4 |
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
|
May 4 |
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
|